首页 > 最新文献
paperpass

Infectious Diseases: Research and Treatment最新文献

英文 中文
Updated Antimicrobial Therapy for the Prevention and Treatment of Endocarditis: Focus on Daptomycin 预防和治疗心内膜炎的最新抗菌疗法:重点是达托霉素
Pub Date : 2012-01-01 DOI: 10.4137/IDRT.S7579
A. González-Ruiz, Annie M Jones
Infective endocarditis is associated with significant clinical mortality and morbidity. With the increasing age of the general population and use of intra-cardiac devices it is occurring mainly in people over the age of 60 with male to female ratios ranging from 3:2 to 9. The predominant causative pathogens are staphylococci, and with the increase in the number of pathogens that are either resistant or exhibit reduced susceptibility the management of infective endocarditis is increasingly challenging. Recent guidelines have included the lipopeptide, daptomycin, in their recommendations. The body of evidence supporting the use of daptomycin in the treatment of infective endocarditis, including at doses above the licensed recommended dose of 6 mg/kg is increasing. The current review summarises the current recommendations for infective endocarditis and the place of daptomycin in its management.
感染性心内膜炎与显著的临床死亡率和发病率相关。随着一般人群年龄的增长和心脏内装置的使用,它主要发生在60岁以上的人群中,男女比例从3:2到9不等。主要的致病病原体是葡萄球菌,随着耐药或易感性降低的病原体数量的增加,感染性心内膜炎的管理越来越具有挑战性。最近的指南建议使用脂肽达托霉素。越来越多的证据支持使用达托霉素治疗感染性心内膜炎,包括超过许可推荐剂量6mg /kg的剂量。本综述总结了目前对感染性心内膜炎的建议以及达托霉素在其治疗中的地位。
{"title":"Updated Antimicrobial Therapy for the Prevention and Treatment of Endocarditis: Focus on Daptomycin","authors":"A. González-Ruiz, Annie M Jones","doi":"10.4137/IDRT.S7579","DOIUrl":"https://doi.org/10.4137/IDRT.S7579","url":null,"abstract":"Infective endocarditis is associated with significant clinical mortality and morbidity. With the increasing age of the general population and use of intra-cardiac devices it is occurring mainly in people over the age of 60 with male to female ratios ranging from 3:2 to 9. The predominant causative pathogens are staphylococci, and with the increase in the number of pathogens that are either resistant or exhibit reduced susceptibility the management of infective endocarditis is increasingly challenging. Recent guidelines have included the lipopeptide, daptomycin, in their recommendations. The body of evidence supporting the use of daptomycin in the treatment of infective endocarditis, including at doses above the licensed recommended dose of 6 mg/kg is increasing. The current review summarises the current recommendations for infective endocarditis and the place of daptomycin in its management.","PeriodicalId":190866,"journal":{"name":"Infectious Diseases: Research and Treatment","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115602109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute versus Chronic Invasive Fungal Rhinosinusitis: A Case-Control Study 急性与慢性侵袭性真菌性鼻窦炎:一项病例对照研究
Pub Date : 2012-01-01 DOI: 10.4137/IDRT.S9818
P. Piromchai, S. Thanaviratananich
Introduction Invasive fungal rhinosinusitis is a challenging condition that can be found mostly in immunocompromised patients. Failure to diagnose and treat this entity promptly usually results in rapid progression and death. The purpose of this study was to determine clinical presentation, complication and morbidity in patients with acute versus chronic invasive fungal rhinosinusitis. Setting and design Case-control study at Srinagarind Hospital, Khon Kaen University between January 1998 and May 2008. Methods The patient's data with the diagnosis of invasive fungal rhinosinusitis was included. Demographic data, underlying diseases, presenting symptoms, histologic sinonasal tissue evaluations, sinonasal tissue cultures, CT scan findings, surgical interventions, morbidity, and mortality were collected. Results Sixty-five patients were diagnosed as invasive fungal rhinosinusitis between January 1998 and May 2008. The data of six patients were unable to obtain. Fifty-nine patients were included in this study. Patients with immunocompromised status have significant greater risk for acute than chronic IFS, OR = 6.5 (P = 0.004). Patients with mucosal necrosis have the significant higher risk for acute IFS, OR = 5.5 (P = 0.01). There was no significant difference in orbital complications proportion between acute and chronic invasive fungal rhinosinusitis, OR = 2.42 (P = 0.15). Sinus wall erosion have found significantly in chronic IFS group, OR = 0.24 (P = 0.02). The average hospital stayed was 30.58 ± 26.43 days with no difference between groups (P = 0.50). Fourteen patients in acute IFS group were dead (31.11%) while all patients in chronic IFS group were survived. Conclusions Invasive fungal rhinosinusitis continues to present a challenge to the otolaryngologist. Acute IFS was found most commonly in immunocompromised patients. The most consistent finding of acute IFS was mucosal necrosis and black crust/debris. The CT finding of sinus wall erosion may help in diagnosis of chronic IFS.
侵袭性真菌性鼻窦炎是一种具有挑战性的疾病,主要发生在免疫功能低下的患者中。如果不能及时诊断和治疗,通常会导致病情迅速恶化和死亡。本研究的目的是确定急性和慢性侵袭性真菌性鼻窦炎患者的临床表现、并发症和发病率。1998年1月至2008年5月在孔庆大学斯利那加林医院进行的病例对照研究。方法收集诊断为侵袭性真菌性鼻窦炎的患者资料。收集人口统计学资料、基础疾病、表现症状、鼻组织组织学评估、鼻组织培养、CT扫描结果、手术干预、发病率和死亡率。结果1998年1月~ 2008年5月确诊为侵袭性真菌性鼻窦炎65例。6例患者的数据无法获得。59例患者纳入本研究。免疫功能低下的患者发生急性IFS的风险显著高于慢性IFS, OR = 6.5 (P = 0.004)。粘膜坏死患者发生急性IFS的风险显著增高,OR = 5.5 (P = 0.01)。急性和慢性侵袭性真菌性鼻窦炎患者眼眶并发症比例差异无统计学意义,OR = 2.42 (P = 0.15)。慢性IFS组有明显的窦壁侵蚀,OR = 0.24 (P = 0.02)。患者平均住院时间为30.58±26.43 d,两组间差异无统计学意义(P = 0.50)。急性IFS组死亡14例(31.11%),慢性IFS组全部存活。结论侵袭性真菌性鼻窦炎对耳鼻喉科医生来说仍然是一个挑战。急性IFS最常见于免疫功能低下的患者。急性IFS最一致的表现是粘膜坏死和黑色结痂/碎屑。窦壁糜烂的CT表现有助于慢性IFS的诊断。
{"title":"Acute versus Chronic Invasive Fungal Rhinosinusitis: A Case-Control Study","authors":"P. Piromchai, S. Thanaviratananich","doi":"10.4137/IDRT.S9818","DOIUrl":"https://doi.org/10.4137/IDRT.S9818","url":null,"abstract":"Introduction Invasive fungal rhinosinusitis is a challenging condition that can be found mostly in immunocompromised patients. Failure to diagnose and treat this entity promptly usually results in rapid progression and death. The purpose of this study was to determine clinical presentation, complication and morbidity in patients with acute versus chronic invasive fungal rhinosinusitis. Setting and design Case-control study at Srinagarind Hospital, Khon Kaen University between January 1998 and May 2008. Methods The patient's data with the diagnosis of invasive fungal rhinosinusitis was included. Demographic data, underlying diseases, presenting symptoms, histologic sinonasal tissue evaluations, sinonasal tissue cultures, CT scan findings, surgical interventions, morbidity, and mortality were collected. Results Sixty-five patients were diagnosed as invasive fungal rhinosinusitis between January 1998 and May 2008. The data of six patients were unable to obtain. Fifty-nine patients were included in this study. Patients with immunocompromised status have significant greater risk for acute than chronic IFS, OR = 6.5 (P = 0.004). Patients with mucosal necrosis have the significant higher risk for acute IFS, OR = 5.5 (P = 0.01). There was no significant difference in orbital complications proportion between acute and chronic invasive fungal rhinosinusitis, OR = 2.42 (P = 0.15). Sinus wall erosion have found significantly in chronic IFS group, OR = 0.24 (P = 0.02). The average hospital stayed was 30.58 ± 26.43 days with no difference between groups (P = 0.50). Fourteen patients in acute IFS group were dead (31.11%) while all patients in chronic IFS group were survived. Conclusions Invasive fungal rhinosinusitis continues to present a challenge to the otolaryngologist. Acute IFS was found most commonly in immunocompromised patients. The most consistent finding of acute IFS was mucosal necrosis and black crust/debris. The CT finding of sinus wall erosion may help in diagnosis of chronic IFS.","PeriodicalId":190866,"journal":{"name":"Infectious Diseases: Research and Treatment","volume":"35 3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123465876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
2009H1N1 Influenza in Immunocompetent and Immunocompromised Patients 2009免疫正常和免疫功能低下患者的h1n1流感
Pub Date : 2012-01-01 DOI: 10.4137/IDRT.S9226
R. Moss
The treatment and prevention of influenza virus infection has been associated with two major challenges that are exemplified by 2009H1N1 as well as previous pandemics. The constant evolutionary pressure on the influenza virus can result in novel strains which may not be optimally protected by vaccines or currently approved antivirals. Selection for antiviral resistance mutations can occur over time. Prolonged virus shedding, selection for resistance mutations, and cross resistance, can be exacerbated and problematic in immunocompromised patients. This review will cover 2009H1N1 infection in immuno-competent and immunocompromised individuals. Influenza continues to be a major public health concern and these challenges make influenza a suitable area for new vaccine and antiviral approaches.
治疗和预防流感病毒感染与两大挑战有关,2009年h1n1流感和以前的大流行病就是例证。流感病毒的持续进化压力可能导致新的毒株,这些毒株可能无法得到疫苗或目前批准的抗病毒药物的最佳保护。抗病毒抗性突变的选择可能随着时间的推移而发生。在免疫功能低下的患者中,延长的病毒脱落、抗性突变的选择和交叉抗性可能会加剧和产生问题。本综述将涵盖免疫正常和免疫功能低下个体的2009H1N1感染。流感仍然是一个主要的公共卫生问题,这些挑战使流感成为新疫苗和抗病毒方法的合适领域。
{"title":"2009H1N1 Influenza in Immunocompetent and Immunocompromised Patients","authors":"R. Moss","doi":"10.4137/IDRT.S9226","DOIUrl":"https://doi.org/10.4137/IDRT.S9226","url":null,"abstract":"The treatment and prevention of influenza virus infection has been associated with two major challenges that are exemplified by 2009H1N1 as well as previous pandemics. The constant evolutionary pressure on the influenza virus can result in novel strains which may not be optimally protected by vaccines or currently approved antivirals. Selection for antiviral resistance mutations can occur over time. Prolonged virus shedding, selection for resistance mutations, and cross resistance, can be exacerbated and problematic in immunocompromised patients. This review will cover 2009H1N1 infection in immuno-competent and immunocompromised individuals. Influenza continues to be a major public health concern and these challenges make influenza a suitable area for new vaccine and antiviral approaches.","PeriodicalId":190866,"journal":{"name":"Infectious Diseases: Research and Treatment","volume":"74 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122628400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Genetic Polymorphism of Plasmodium falciparum Merozoite Surface Protein-1 and -2 and Diversity of Drug Resistance Genes in Blood Donors from Bamako, Mali 马里巴马科献血者恶性疟原虫Merozoite表面蛋白-1和-2遗传多态性及耐药基因多样性
Pub Date : 2012-01-01 DOI: 10.4137/IDRT.S10094
B. Thomas, C. Petrella, Stephanie R. Crespo, Tanya J. Thakur, J. Moulds, D. Diallo
We examined malaria infection in asymptomatic blood donors from Mali, analyzing allelic diversity of Plasmodium falciparum (Pf) merozoite surface proteins (msp) -1 and -2 as well as the distribution of sulphadoxine-pyrimethamine (SP) resistance genes. A total of 140 genomic DNA samples were screened. Allele-specific nested polymerase chain reaction (PCR) analysis of Pfmsp-1 and Pfmsp-2 was performed, plus fragment analysis of the polymorphic regions to identify allelic diversity of the parasite population. We found parasite positivity due to Pf alone in 20.7% of these donors. Diverse allelic polymorphism of Pfmsp-1 and Pfmsp-2 was identified, with a high rate of multiplicity of infection (1.84 and 1.82 for Pfmsp-1 and Pfmsp-2, respectively). In addition, we found a high degree of SP resistance, with mutations at several dhfr and dhps codons. We conclude that there is an extensive diversity of Pfmsp-1 and Pfmsp-2 allelic types and SP drug resistance in Pf-infected donors from Mali.
我们检测了马里无症状献血者的疟疾感染情况,分析了恶性疟原虫(Pf) merozoite表面蛋白(msp) -1和-2的等位基因多样性以及磺胺嘧啶-乙胺嘧啶(SP)抗性基因的分布。总共筛选了140个基因组DNA样本。对Pfmsp-1和Pfmsp-2进行了等位基因特异性巢式聚合酶链反应(PCR)分析,并对多态性区域进行了片段分析,以确定寄生虫种群的等位基因多样性。我们发现20.7%的献血者仅因Pf而呈寄生虫阳性。Pfmsp-1和Pfmsp-2等位基因多态性多样,具有较高的感染多重率(分别为1.84和1.82)。此外,我们发现了高度的SP抗性,在几个dhfr和dhps密码子上发生突变。我们得出结论,Pfmsp-1和Pfmsp-2等位基因类型存在广泛的多样性,并且在马里感染了pfmsp的供体中存在对SP的耐药性。
{"title":"Genetic Polymorphism of Plasmodium falciparum Merozoite Surface Protein-1 and -2 and Diversity of Drug Resistance Genes in Blood Donors from Bamako, Mali","authors":"B. Thomas, C. Petrella, Stephanie R. Crespo, Tanya J. Thakur, J. Moulds, D. Diallo","doi":"10.4137/IDRT.S10094","DOIUrl":"https://doi.org/10.4137/IDRT.S10094","url":null,"abstract":"We examined malaria infection in asymptomatic blood donors from Mali, analyzing allelic diversity of Plasmodium falciparum (Pf) merozoite surface proteins (msp) -1 and -2 as well as the distribution of sulphadoxine-pyrimethamine (SP) resistance genes. A total of 140 genomic DNA samples were screened. Allele-specific nested polymerase chain reaction (PCR) analysis of Pfmsp-1 and Pfmsp-2 was performed, plus fragment analysis of the polymorphic regions to identify allelic diversity of the parasite population. We found parasite positivity due to Pf alone in 20.7% of these donors. Diverse allelic polymorphism of Pfmsp-1 and Pfmsp-2 was identified, with a high rate of multiplicity of infection (1.84 and 1.82 for Pfmsp-1 and Pfmsp-2, respectively). In addition, we found a high degree of SP resistance, with mutations at several dhfr and dhps codons. We conclude that there is an extensive diversity of Pfmsp-1 and Pfmsp-2 allelic types and SP drug resistance in Pf-infected donors from Mali.","PeriodicalId":190866,"journal":{"name":"Infectious Diseases: Research and Treatment","volume":"174 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122999101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Neurobrucellosis: Challenges for Therapy 神经布鲁氏菌病:治疗挑战
Pub Date : 2012-01-01 DOI: 10.4137/IDRT.S8649
A. Alothman, Saud Al Dubayan, A. Khathaami, S. Kojan, S. B. Salih
Background Brucellosis is a common zoonotic infection throughout the world, and is endemic in Saudi Arabia. Neurobrucellosis is a rare, severe form of systemic brucella infection. Treatment of neurobrucellosis continues to be variable, depending on the location of diagnosis. Methods A retrospective patient chart review was undertaken from 1995 to 2010 at King Abdulaziz Medical City, Riyadh, to identify cases of neurobrucellosis following a proposed case definition. Follow-up visits were evaluated to determine response to treatment. Results A total of 22 cases of neurobrucellosis were identified from a total of 517 cases of brucellosis. The mean patient age was 42.5 years with a male to female ratio of 1:1. Most antibiotic combinations included doxycycline, rifampin, and cotrimoxazole (36%). Three patients received ciprofloxacin in combination with other antibiotics and showed a satisfactory response. Conclusion Combination of antibrucella antibiotics is recommended, but there are no clear guidelines regarding antibiotic selection and duration of therapy. The use of ciprofloxacin in cases of neurobrucellosis should be evaluated.
布鲁氏菌病是世界各地常见的人畜共患感染,在沙特阿拉伯流行。神经布鲁氏菌病是一种罕见的、严重的全身性布鲁氏菌感染。神经布鲁氏菌病的治疗仍然是可变的,取决于诊断的位置。方法对利雅得阿卜杜勒阿齐兹国王医疗城1995年至2010年的患者病历进行回顾性分析,根据拟议的病例定义确定神经布鲁氏菌病病例。对随访进行评估以确定对治疗的反应。结果从517例布鲁氏菌病中共检出22例神经布鲁氏菌病。患者平均年龄42.5岁,男女比例为1:1。大多数抗生素组合包括强力霉素、利福平和复方新诺明(36%)。3例患者采用环丙沙星联合其他抗生素治疗,疗效满意。结论推荐联合使用抗布鲁氏菌抗生素,但在抗生素的选择和治疗时间方面尚无明确的指导方针。应评估在神经布鲁氏菌病病例中使用环丙沙星。
{"title":"Neurobrucellosis: Challenges for Therapy","authors":"A. Alothman, Saud Al Dubayan, A. Khathaami, S. Kojan, S. B. Salih","doi":"10.4137/IDRT.S8649","DOIUrl":"https://doi.org/10.4137/IDRT.S8649","url":null,"abstract":"Background Brucellosis is a common zoonotic infection throughout the world, and is endemic in Saudi Arabia. Neurobrucellosis is a rare, severe form of systemic brucella infection. Treatment of neurobrucellosis continues to be variable, depending on the location of diagnosis. Methods A retrospective patient chart review was undertaken from 1995 to 2010 at King Abdulaziz Medical City, Riyadh, to identify cases of neurobrucellosis following a proposed case definition. Follow-up visits were evaluated to determine response to treatment. Results A total of 22 cases of neurobrucellosis were identified from a total of 517 cases of brucellosis. The mean patient age was 42.5 years with a male to female ratio of 1:1. Most antibiotic combinations included doxycycline, rifampin, and cotrimoxazole (36%). Three patients received ciprofloxacin in combination with other antibiotics and showed a satisfactory response. Conclusion Combination of antibrucella antibiotics is recommended, but there are no clear guidelines regarding antibiotic selection and duration of therapy. The use of ciprofloxacin in cases of neurobrucellosis should be evaluated.","PeriodicalId":190866,"journal":{"name":"Infectious Diseases: Research and Treatment","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130262429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Maraviroc in Antiretroviral-Naïve HIV-1 Patients 马拉韦洛克治疗Antiretroviral-Naïve HIV-1患者
Pub Date : 2012-01-01 DOI: 10.4137/IDRT.S7597
B. Ghebremedhin
New antiretroviral agents that are better tolerated with less side effects and novel resistance patterns are needed at all lines of human immunodeficiency virus (HIV) therapeutic strategies. The CC-chemokine receptor 5 (CCR5) antagonist maraviroc is a member of the novel class of “antiretroviral agents” that prevents the entry of HIV-1 into host cells by blocking the CCR5 coreceptor. In the MERIT (Maraviroc versus Efavirenz in Treatment-Naïve Patients) study in antiretrovial-naïve patients aged ≥16 years with CCR5-tropic HIV-1 infection, maraviroc showed noninferiority to efavirenz for virological endpoints. Evidences from trials suggest that maraviroc is effective at reducing HIV-1 viral load in antiretroviral-experienced and -naïve patients with CCR5-tropic virus, as well as in those with CCR5-tropic virus who have developed HIV-1 resistance to existing antiretroviral regimens. Recent in vitro study demonstrated that maraviroc was also active against CCR5-tropic HIV-2 strains.
人类免疫缺陷病毒(HIV)的所有治疗策略都需要耐受性更好、副作用更小和新的耐药模式的新型抗逆转录病毒药物。cc趋化因子受体5 (CCR5)拮抗剂maraviroc是新型“抗逆转录病毒药物”的一员,通过阻断CCR5辅助受体来阻止HIV-1进入宿主细胞。在对antiretrovial-naïve年龄≥16岁的趋化ccr5的HIV-1感染患者进行的MERIT(马拉韦洛克与依非韦伦在Treatment-Naïve患者中的对比)研究中,在病毒学终点上,马拉韦洛克与依非韦伦表现出非劣效性。来自试验的证据表明,马拉韦洛克在抗逆转录病毒治疗经历和-naïve ccr5 -嗜性病毒患者以及对现有抗逆转录病毒治疗方案产生HIV-1耐药性的ccr5 -嗜性病毒患者中,可有效降低HIV-1病毒载量。最近的体外研究表明,马拉韦洛克对嗜ccr5的HIV-2毒株也有活性。
{"title":"Maraviroc in Antiretroviral-Naïve HIV-1 Patients","authors":"B. Ghebremedhin","doi":"10.4137/IDRT.S7597","DOIUrl":"https://doi.org/10.4137/IDRT.S7597","url":null,"abstract":"New antiretroviral agents that are better tolerated with less side effects and novel resistance patterns are needed at all lines of human immunodeficiency virus (HIV) therapeutic strategies. The CC-chemokine receptor 5 (CCR5) antagonist maraviroc is a member of the novel class of “antiretroviral agents” that prevents the entry of HIV-1 into host cells by blocking the CCR5 coreceptor. In the MERIT (Maraviroc versus Efavirenz in Treatment-Naïve Patients) study in antiretrovial-naïve patients aged ≥16 years with CCR5-tropic HIV-1 infection, maraviroc showed noninferiority to efavirenz for virological endpoints. Evidences from trials suggest that maraviroc is effective at reducing HIV-1 viral load in antiretroviral-experienced and -naïve patients with CCR5-tropic virus, as well as in those with CCR5-tropic virus who have developed HIV-1 resistance to existing antiretroviral regimens. Recent in vitro study demonstrated that maraviroc was also active against CCR5-tropic HIV-2 strains.","PeriodicalId":190866,"journal":{"name":"Infectious Diseases: Research and Treatment","volume":"532 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116707376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Mapping Historic Hookworm Disease Prevalence in the Southern Us, Comparing Percent Prevalence with Percent Soil Drainage Type Using GIS 利用GIS绘制美国南部历史钩虫病流行率,比较流行率与土壤排水类型百分比
Pub Date : 2011-01-01 DOI: 10.4137/IDRT.S6762
A. Anderson, T. Allen
Mapping of Historic US Hookworm prevalence data from the Rockefeller Sanitary Commission (early 1900s) using current GIS (Geographic Information System) software (county shape files) illustrates the extremely high prevalence of hookworm disease (Uncariasis) in the Southeastern US at the time. Some counties in 7 states recorded 50% to 100% of the population with positive screens for hookworm in a monumental surveillance and treatment campaign. Narrative descriptions mentioned higher prevalence in “sand districts” vs. “clay districts”. In order to validate this description for historic data, further GIS databases (STATSGO) were used to classify and quantify the % acreage in Eastern North Carolina falling into moderately- to well-drained soil types. These were then mapped and compared with the historic prevalence data. Most severely infested counties had at least 50% moderately to well-drained soil. Further analysis on soil data for other states with “coastal plains” could provide more background information on Environmental conditions for hookworm prevalence and distribution in US history. “Since history has no properly scientific value, its only purpose is educative. And if historians neglect to educate the public, if they fail to interest it intelligently in the past, then all their historical learning is valueless except in so far as it educates themselves”. Trevelyan, (1922).
洛克菲勒卫生委员会(20世纪初)使用当前的GIS(地理信息系统)软件(县形状文件)绘制的美国历史钩虫流行数据图说明了当时美国东南部钩虫病(钩蚴病)的极高流行率。在7个州的一些县,在一项大规模的监测和治疗运动中,钩虫筛查呈阳性的人口达到50%至100%。叙述性描述提到“沙区”比“粘土区”的患病率更高。为了验证这一历史数据的描述,进一步使用GIS数据库(STATSGO)对北卡罗来纳州东部属于中等至良好排水土壤类型的百分比面积进行分类和量化。然后绘制这些数据,并与历史流行数据进行比较。最严重的侵染县至少有50%的中度至良好排水土壤。进一步分析其他“沿海平原”州的土壤数据,可以为美国历史上钩虫流行和分布的环境条件提供更多的背景信息。由于历史没有真正的科学价值,它的唯一目的就是教育。如果历史学家忽视了对公众的教育,如果他们不能使公众对过去产生明智的兴趣,那么,他们所有的历史学习都是毫无价值的,除非它能教育他们自己。”特里维廉,(1922)。
{"title":"Mapping Historic Hookworm Disease Prevalence in the Southern Us, Comparing Percent Prevalence with Percent Soil Drainage Type Using GIS","authors":"A. Anderson, T. Allen","doi":"10.4137/IDRT.S6762","DOIUrl":"https://doi.org/10.4137/IDRT.S6762","url":null,"abstract":"Mapping of Historic US Hookworm prevalence data from the Rockefeller Sanitary Commission (early 1900s) using current GIS (Geographic Information System) software (county shape files) illustrates the extremely high prevalence of hookworm disease (Uncariasis) in the Southeastern US at the time. Some counties in 7 states recorded 50% to 100% of the population with positive screens for hookworm in a monumental surveillance and treatment campaign. Narrative descriptions mentioned higher prevalence in “sand districts” vs. “clay districts”. In order to validate this description for historic data, further GIS databases (STATSGO) were used to classify and quantify the % acreage in Eastern North Carolina falling into moderately- to well-drained soil types. These were then mapped and compared with the historic prevalence data. Most severely infested counties had at least 50% moderately to well-drained soil. Further analysis on soil data for other states with “coastal plains” could provide more background information on Environmental conditions for hookworm prevalence and distribution in US history. “Since history has no properly scientific value, its only purpose is educative. And if historians neglect to educate the public, if they fail to interest it intelligently in the past, then all their historical learning is valueless except in so far as it educates themselves”. Trevelyan, (1922).","PeriodicalId":190866,"journal":{"name":"Infectious Diseases: Research and Treatment","volume":"108 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117285440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Molecular Genetic Diagnostic Strategy to Help Clinicians to a Better Assessment of the Heaviness of a Human Papilloma Virus (HPV) Infection 分子遗传诊断策略,以帮助临床医生更好地评估人类乳头瘤病毒(HPV)感染的严重性
Pub Date : 2011-01-01 DOI: 10.4137/IDRT.S6646
F. Heirler, E. Z̆dárský, R. Borelli, H. Heppner
Since the introduction of a cytology-based screening program for cervical cancer in developed countries a dramatic reduction of specific morbidity and mortality has been reported. In addition to this in 1972 zur Hausen proposed HPV as a causal factor of cervical cancer. About 15 viral subtypes have been identified: the so called high-risk subtypes for cancer development. Despite this the clinical use of subtype identification in a prevention strategy has not substantially been reported. Simple identification of HPV carrier status cannot reliably be used as a prognostic factor for cervical cancer development nor as a useful alternative to cytological examination. Therefore we are establishing a link between the classical cytological examination and the techniques of molecular biology. Our strategy detects HPV in a semi-quantitative way as well as the E7-m-RNA activity and T-lymphocyte-transformation in order to better calculate how serious an infection is, how active the virus and how active the defense reaction is.
据报道,自从发达国家采用细胞学为基础的宫颈癌筛查方案以来,特定发病率和死亡率显著降低。除此之外,1972年zur Hausen提出HPV是宫颈癌的一个致病因素。已经确定了大约15种病毒亚型:所谓的癌症发展的高风险亚型。尽管如此,亚型识别在预防策略中的临床应用还没有实质性的报道。单纯确定HPV携带者状态不能可靠地作为宫颈癌发展的预后因素,也不能作为细胞学检查的有用替代方法。因此,我们正在建立经典细胞学检查和分子生物学技术之间的联系。我们的策略以半定量的方式检测HPV,以及E7-m-RNA活性和t淋巴细胞转化,以便更好地计算感染的严重程度,病毒的活跃程度以及防御反应的活跃程度。
{"title":"Molecular Genetic Diagnostic Strategy to Help Clinicians to a Better Assessment of the Heaviness of a Human Papilloma Virus (HPV) Infection","authors":"F. Heirler, E. Z̆dárský, R. Borelli, H. Heppner","doi":"10.4137/IDRT.S6646","DOIUrl":"https://doi.org/10.4137/IDRT.S6646","url":null,"abstract":"Since the introduction of a cytology-based screening program for cervical cancer in developed countries a dramatic reduction of specific morbidity and mortality has been reported. In addition to this in 1972 zur Hausen proposed HPV as a causal factor of cervical cancer. About 15 viral subtypes have been identified: the so called high-risk subtypes for cancer development. Despite this the clinical use of subtype identification in a prevention strategy has not substantially been reported. Simple identification of HPV carrier status cannot reliably be used as a prognostic factor for cervical cancer development nor as a useful alternative to cytological examination. Therefore we are establishing a link between the classical cytological examination and the techniques of molecular biology. Our strategy detects HPV in a semi-quantitative way as well as the E7-m-RNA activity and T-lymphocyte-transformation in order to better calculate how serious an infection is, how active the virus and how active the defense reaction is.","PeriodicalId":190866,"journal":{"name":"Infectious Diseases: Research and Treatment","volume":"91 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114231886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Update on Neglected Tropical Diseases of the Western Hemisphere 关于西半球被忽视热带病的最新情况
Pub Date : 2011-01-01 DOI: 10.4137/IDRT.S7401
E. Fischer, C. Macpherson
Neglected Tropical Diseases (NTDs) are responsible for millions of deaths and disabilities yearly, around the globe. The largest burden of these diseases falls on communities with poor access to basic sanitation, healthcare facilities, and educational programs. This review focuses on advances in vaccination, treatment and control programs over the past decade for the major NTDs of the Western Hemisphere: malaria, schistosomiasis, leishmaniasis, ankylostomiasis, lymphatic filiariasis, Chagas disease (American trypanosomiasis), and onchocerciasis. The discussion centers on challenges for NTD eradication and prospects for the future.
被忽视的热带病每年在全球造成数百万人死亡和残疾。这些疾病的最大负担落在难以获得基本卫生设施、医疗保健设施和教育计划的社区。本综述侧重于过去十年在西半球主要被忽视热带病(疟疾、血吸虫病、利什曼病、钩虫病、淋巴丝虫病、恰加斯病(美洲锥虫病)和盘尾丝虫病)的疫苗接种、治疗和控制规划方面的进展。讨论的重点是消灭非传染性疾病的挑战和未来的前景。
{"title":"Update on Neglected Tropical Diseases of the Western Hemisphere","authors":"E. Fischer, C. Macpherson","doi":"10.4137/IDRT.S7401","DOIUrl":"https://doi.org/10.4137/IDRT.S7401","url":null,"abstract":"Neglected Tropical Diseases (NTDs) are responsible for millions of deaths and disabilities yearly, around the globe. The largest burden of these diseases falls on communities with poor access to basic sanitation, healthcare facilities, and educational programs. This review focuses on advances in vaccination, treatment and control programs over the past decade for the major NTDs of the Western Hemisphere: malaria, schistosomiasis, leishmaniasis, ankylostomiasis, lymphatic filiariasis, Chagas disease (American trypanosomiasis), and onchocerciasis. The discussion centers on challenges for NTD eradication and prospects for the future.","PeriodicalId":190866,"journal":{"name":"Infectious Diseases: Research and Treatment","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131298134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Hematologic Abnormalities in Treatment-naïve HIV Patients Treatment-naïve HIV患者血液学异常
Pub Date : 2010-01-01 DOI: 10.4137/IDRT.S6033
A. Akinbami, O. Oshinaike, T. Adeyemo, A. Adediran, O. Dosunmu, M. Dada, I. Durojaiye, A. Adebola, O. Vincent
Objectives Hematologic abnormalities, indicated by a deranged full blood count, are common manifestations and important prognostic tools for human immunodeficiency virus (HIV) infection and AIDS. This study aimed to determine the prevalence of cytopenia and its relationship to the degree of immunosupression in HIV treatment-naïve patients. Methods This was a cross-sectional study of treatment-naïve HIV-infected clients who enrolled at the HIV clinic of Lagos State University Teaching Hospital (LASUTH) between December 2009 and June 2010. Participants had samples taken for full blood count and CD4 counts, which are free routine pre-requisite and pre-treatment evaluations done for all registered HIV patients at LASUTH. They were asked to fill the structured questionnaires to obtain demographic data, with assistance if necessary. Results A total of 205 cases were reviewed: 24.2% had anemia (PCV < 30%), 26.8% had leucopenia (white blood cell <4,000/L) and 16.1% had thrombocytopenia (platelet count <150,000/L) at enrollment. The degree of cytopenia was directly related to the degree of immunosupression. Conclusion About one-fifth of HIV treatment-naïve patients were cytopenic at enrollment and the degree of cytopenia was directly related to the degree of immunosupression. It is necessary to investigate various causes of cytopenia in these patients so as to administer a specific intervention.
目的血液学异常是人类免疫缺陷病毒(HIV)感染和艾滋病的常见表现和重要预后工具,其指标为全血细胞计数紊乱。本研究旨在确定HIV treatment-naïve患者中细胞减少的患病率及其与免疫抑制程度的关系。方法对2009年12月至2010年6月期间在拉各斯州立大学教学医院(LASUTH) HIV门诊登记的treatment-naïve HIV感染患者进行横断面研究。参与者采集了全血细胞计数和CD4计数样本,这是LASUTH所有登记的艾滋病毒患者的免费常规先决条件和治疗前评估。他们被要求填写结构化问卷以获得人口统计数据,必要时还会得到帮助。结果共回顾205例患者,入组时24.2%的患者有贫血(PCV < 30%), 26.8%的患者有白细胞减少(白细胞<4,000/L), 16.1%的患者有血小板减少(血小板计数<150,000/L)。细胞减少程度与免疫抑制程度直接相关。结论约五分之一的HIV treatment-naïve患者入组时细胞减少,细胞减少程度与免疫抑制程度直接相关。有必要调查导致这些患者细胞减少的各种原因,以便采取具体的干预措施。
{"title":"Hematologic Abnormalities in Treatment-naïve HIV Patients","authors":"A. Akinbami, O. Oshinaike, T. Adeyemo, A. Adediran, O. Dosunmu, M. Dada, I. Durojaiye, A. Adebola, O. Vincent","doi":"10.4137/IDRT.S6033","DOIUrl":"https://doi.org/10.4137/IDRT.S6033","url":null,"abstract":"Objectives Hematologic abnormalities, indicated by a deranged full blood count, are common manifestations and important prognostic tools for human immunodeficiency virus (HIV) infection and AIDS. This study aimed to determine the prevalence of cytopenia and its relationship to the degree of immunosupression in HIV treatment-naïve patients. Methods This was a cross-sectional study of treatment-naïve HIV-infected clients who enrolled at the HIV clinic of Lagos State University Teaching Hospital (LASUTH) between December 2009 and June 2010. Participants had samples taken for full blood count and CD4 counts, which are free routine pre-requisite and pre-treatment evaluations done for all registered HIV patients at LASUTH. They were asked to fill the structured questionnaires to obtain demographic data, with assistance if necessary. Results A total of 205 cases were reviewed: 24.2% had anemia (PCV < 30%), 26.8% had leucopenia (white blood cell <4,000/L) and 16.1% had thrombocytopenia (platelet count <150,000/L) at enrollment. The degree of cytopenia was directly related to the degree of immunosupression. Conclusion About one-fifth of HIV treatment-naïve patients were cytopenic at enrollment and the degree of cytopenia was directly related to the degree of immunosupression. It is necessary to investigate various causes of cytopenia in these patients so as to administer a specific intervention.","PeriodicalId":190866,"journal":{"name":"Infectious Diseases: Research and Treatment","volume":"387 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123240006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 56
期刊
Infectious Diseases: Research and Treatment
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
mjeditor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1